Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

ARNA 4.16 +0.05 (1.09%)
price chart
Trading Volume Shifts: Image Sensing Systems, Inc.(NASDAQ:ISNS), Arena ...
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) gained seven cents to finish the day at a closing price of $4.25, a 1.67% increase in value from the previous closing price.
Related articles »  
Arena Pharmaceuticals Posts Increased Revenue In Second Quarter
Arena Pharmaceuticals, Inc. (ARNA) reported financial results for the second quarter of its fiscal year 2014 (2QFY14) before the market opened today.
Arena Pharmaceuticals Provides Corporate Update and Reports Second ...  MarketWatch
Arena Pharmaceuticals Inc.: Arena Pharmaceuticals Provides Corporate Update ...  The Wall Street Transcript
Related articles »  
Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T ...
On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts' consensus estimate of ($0.11) by $0.14.
Advertising And The Belviq Re-Launch
July of 2014 marked the "re-launch" of the anti-obesity drug Belviq from Arena Pharmaceuticals (NASDAQ:ARNA) and marketing partner Eisai (OTCPK:ESALY). Belviq had its initial launch in June of ... Needless to say, Arena stock suffered because sales ...
Related articles »  
Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss
Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) fell approximately 3.7% after the company reported a net loss (excluding one-time items) of 12 cents per share in the second quarter of 2014 wider than the Zacks Consensus Estimate of loss of 11 cents.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Dips As Loss Goes Beyond ...  FinancialsTrend
Belviq Scripts Flat For Arena (ARNA)  Seeking Alpha (registration)
Related articles »  
Shining on Major News: Google Inc (NASDAQ:GOOG), Arena Pharmaceuticals ...
On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the second quarter ended June 30, 2014.
Related articles »  
News Buzz: Netflix, Inc. (NASDAQ:NFLX), Arena Pharmaceuticals, Inc ...
On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the second quarter ended June 30, 2014.
Stocks in the News - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Canadian ...  Techsonian (press release)
Related articles »  
Concerns on Biotech Stocks- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) [Trend Analysis] recently delivered Belviq sales of $3.5M (including $0.4 million from the 15-day free trial voucher redemption).
Related articles »  
Stock Runners: Delta Air Lines Inc. (NYSE:DAL), Arena Pharmaceuticals, Inc ...
On 20 AUG Delta Air Lines Inc. (NYSE:DAL) EVP Glen W. Hauenstein unloaded 47,328 shares of the stock on the open market in a transaction that occurred on Wednesday.
Related articles »  
Potential Investment Options: RadioShack Corporation(NYSE:RSH), Arena ...
RadioShack Corporation(NYSE:RSH) has closed within a range of $0.55 to $1.54 over the past three months. The Texas-based company, which operates in the United States, Europe, South America, and Africa, announced that Standard General, one if its ...
Related articles »